Stay updated on Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma

Sign up to get notified when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.5.4, was added to the page's revision history, indicating an update to the content. The previous Revision: v3.5.3 entry is superseded.
    Difference
    0.1%
    Check dated 2026-05-17T10:21:24.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page’s displayed ClinicalTrials.gov revision/version was updated from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-25T18:26:13.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:18:11.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision history updated to include v3.5.0 and remove v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-20T19:48:28.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. No content changes to the study details or page functionality are evident.
    Difference
    0.1%
    Check dated 2026-03-06T17:49:27.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T13:24:07.000Z thumbnail image

Stay in the know with updates to Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.